𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Anti-Parkinson's disease drugs and pharmacogenetic considerations

✍ Scribed by Agúndez, José A G; García-Martín, Elena; Alonso-Navarro, Hortensia; Jiménez-Jiménez, Félix Javier

Book ID
120187387
Publisher
Informa plc
Year
2013
Tongue
English
Weight
317 KB
Volume
9
Category
Article
ISSN
1742-5255

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Nonsteroidal anti-inflammatory drugs and
Nonsteroidal anti-inflammatory drugs and risk of Parkinson's disease
✍ Thanh G. Ton; Susan R. Heckbert; W.T. Longstreth Jr.; Mary Anne Rossing; Walter 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

## Abstract Inflammation and oxidative stress have been implicated as pathogenic mechanisms in Parkinson's disease (PD). Evidence from in vitro and animal studies suggests a possible protective role of nonsteroidal anti‐inflammatory drugs (NSAIDs), including aspirin. We investigated the risk of PD

Pharmacogenetic Perspectives: Genes, Dru
Pharmacogenetic Perspectives: Genes, Drugs and Disease
✍ Elliot S. Vesell 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 929 KB

Much medical progress has ensued from identification of disease-associated environmental factors. Recent advances emerged from recognition that individuals differ markedly in their susceptibility to environmental injury and that specific genetic factors can increase or decrease this risk. Although d